241 related articles for article (PubMed ID: 9860069)
21. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
Donaldson JA; Glauser TA; Olberding LS
Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
[TBL] [Abstract][Full Text] [Related]
22. Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures.
Tjia-Leong E; Leong K; Marson AG
Cochrane Database Syst Rev; 2010 Dec; (12):CD007783. PubMed ID: 21154386
[TBL] [Abstract][Full Text] [Related]
23. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
[TBL] [Abstract][Full Text] [Related]
24. Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
Frank LM; Enlow T; Holmes GL; Manasco P; Concannon S; Chen C; Womble G; Casale EJ
Epilepsia; 1999 Jul; 40(7):973-9. PubMed ID: 10403222
[TBL] [Abstract][Full Text] [Related]
25. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Schapel G; Chadwick D
Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
[TBL] [Abstract][Full Text] [Related]
26. Use of topiramate in childhood generalized seizure disorders.
Wheless JW
J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
[TBL] [Abstract][Full Text] [Related]
27. Overview of the clinical efficacy of lamotrigine.
Richens A; Yuen AW
Epilepsia; 1991; 32 Suppl 2():S13-6. PubMed ID: 1837775
[TBL] [Abstract][Full Text] [Related]
28. Preliminary open-label experience with topiramate in primary generalized seizures.
Biton V
Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
[TBL] [Abstract][Full Text] [Related]
29. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
Fitton A; Goa KL
Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine.
Steinbaugh L; Szaflarski JP
Drug Des Devel Ther; 2010 Nov; 4():337-42. PubMed ID: 21151621
[TBL] [Abstract][Full Text] [Related]
31. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures.
Jawad S; Richens A; Goodwin G; Yuen WC
Epilepsia; 1989; 30(3):356-63. PubMed ID: 2498073
[TBL] [Abstract][Full Text] [Related]
32. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
33. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
34. Lamotrigine--an update.
Brodie MJ
Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S6-9. PubMed ID: 8951213
[TBL] [Abstract][Full Text] [Related]
35. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
Moeller JJ; Rahey SR; Sadler RM
Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
[TBL] [Abstract][Full Text] [Related]
36. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
37. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
Wong IC; Mawer GE; Sander JW; Lhatoo SD
Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
[TBL] [Abstract][Full Text] [Related]
39. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
[TBL] [Abstract][Full Text] [Related]
40. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures.
Loiseau P; Yuen AW; Duché B; Ménager T; Arné-Bès MC
Epilepsy Res; 1990 Nov; 7(2):136-45. PubMed ID: 2127016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
